Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 199

Sort by

Sort Order Select

Journal Articles

Epigenetic regulation of noncanonical menin targets modulates menin inhibitor response in acute myeloid leukemia

Xinyue Zhou, Lixia Zhang, Sajesan Aryal, Virginia Veasey, Amanda Tajik, Cecilia Restelli, Steven Moreira, Pengcheng Zhang, Yanfeng Zhang, Kristin J. Hope, Yang Zhou, Changde Cheng, Ravi Bhatia, Rui Lu

Blood (2024) 144 (19): 2018–2032.

https://doi.org/10.1182/blood.2023023644

Published: 2024

Includes: Supplemental data

Journal Articles

Low-Dose Decitabine Plus Venetoclax As Post-Transplant Maintenance for High-Risk Myeloid Malignancies

Katherine Parks, Kendall Diebold, Donna Salzman, Antonio Di Stasi, Manuel Espinoza-Gutarra, Ravi Bhatia, Zaid Al-Kadhimi, Omer Jamy

Blood (2023) 142 (Supplement 1): 7052.

https://doi.org/10.1182/blood-2023-184658

Published: 2023

Journal Articles

Leukaemia Exposure Alters the Transcriptional Profile and Function of Macrophages in the Bone Marrow Niche

Martha M. Zarou, Amy Dawson, Bodhayan Prasad, Joana Bittencourt-Silvestre, Désirée Zerbst, Giovanny Rodriguez Blanco, Mary Scott, Karen Dunn, Vaidehi Krishnan, Mhairi Copland, David Vetrie, Ravi Bhatia, Seth Coffelt, S.Tiong Ong, Helen Wheadon, Sara Zanivan, Kristina Kirschner, G. Vignir Helgason

Blood (2023) 142 (Supplement 1): 2704.

https://doi.org/10.1182/blood-2023-181630

Published: 2023

Journal Articles

Addition of Single Dose Gemtuzumab Ozogamicin to Intensive Induction Chemotherapy in Core-Binding Factor Acute Myeloid Leukemia

Garrett Bourne, Kendall Diebold, Manuel Espinoza-Gutarra, Zaid Al-Kadhimi, Kimo Bachiashvili, Sravanti Rangaraju, Pankit Vachhani, Ravi Bhatia, Omer Jamy

Blood (2023) 142 (Supplement 1): 5848.

https://doi.org/10.1182/blood-2023-189853

Published: 2023

Journal Articles

Real-World Evidence of Treatment-Free Remission in Chronic Myeloid Leukemia at an Academic Center in the Deep South

Greg Bascug, Garrett Bourne, Kendall Diebold, Joshua Knapp, Kimo Bachiashvili, Sravanti Rangaraju, Pankit Vachhani, Ravi Bhatia, Omer Jamy

Blood (2023) 142 (Supplement 1): 7425.

https://doi.org/10.1182/blood-2023-184757

Published: 2023

Journal Articles

Idarubicin and Cytarabine with and without Midostaurin for FLT3-Mutated Acute Myeloid Leukemia

Kendall Diebold, Sarah Worth, Kimo Bachiashvili, Pankit Vachhani, Sravanti Rangaraju, Manuel Espinoza-Gutarra, Zaid Al-Kadhimi, Ravi Bhatia, Omer Jamy

Blood (2023) 142 (Supplement 1): 5910.

https://doi.org/10.1182/blood-2023-185198

Published: 2023

Journal Articles

Metabolic adaptation to tyrosine kinase inhibition in leukemia stem cells

Shaowei Qiu, Vipul Sheth, Chengcheng Yan, Juan Liu, Balu K. Chacko, Hui Li, David K. Crossman, Seth D. Fortmann, Sajesan Aryal, Ashley Rennhack, Maria B. Grant, Robert S. Welner, Andrew J. Paterson, Adam R. Wende, Victor M. Darley-Usmar, Rui Lu, Jason W. Locasale, Ravi Bhatia

Blood (2023) 142 (6): 574–588.

https://doi.org/10.1182/blood.2022018196

Published: 2023

Includes: Supplemental data

Journal Articles

The Anti-Leprosy Agent Clofazimine Inhibits FLT3-ITD Mutant AML Stem Cells and Potently Enhances Effects of TKI

Harish Kumar, Andrew J. Paterson, Nick R Anderson, Shaowei Qiu, Sabyasachi Sanyal, Ravi Bhatia

Blood (2022) 140 (Supplement 1): 11533–11534.

https://doi.org/10.1182/blood-2022-169220

Published: 2022

Journal Articles

Optimal Induction and Consolidation Strategy for Patients with Complex Karyotype and TP53 -Mutated Acute Myeloid Leukemia

Omer H Jamy, Kendall Diebold, Kimo Bachiashvili, Sravanti Rangaraju, Pankit Vachhani, Kelly N. Godby, Donna Salzman, Ravi Bhatia

Blood (2022) 140 (Supplement 1): 8959–8960.

https://doi.org/10.1182/blood-2022-160346

Published: 2022

Journal Articles

PRMT5 Inhibition Enhances Elimination of FLT3-ITD AML Stem Cells in Combination with TKI Treatment

Harish Kumar, Aditi Dhir, Andrew J. Paterson, Nick R Anderson, Shaowei Qiu, Xinyang Zhao, Rui Lu, Ravi Bhatia

Blood (2022) 140 (Supplement 1): 3073–3074.

https://doi.org/10.1182/blood-2022-168326

Published: 2022

Journal Articles

Metabolic Adaptation to Tyrosine Kinase Inhibition in Chronic Myelogenous Leukemia Stem Cells

Shaowei Qiu, Vipul Sheth, Chengcheng Yan, Juan Liu, Balu K. Chacko, Hui Li, David Crossman, Seth D. Fortmann, Sajesan Aryal, Maria B. Grant, Robert S. Welner, Andrew J. Paterson, Adam R. Wende, Victor M Darley-Usmar, Rui Lu, Jason W. Locasale, Ravi Bhatia

Blood (2022) 140 (Supplement 1): 3874–3875.

https://doi.org/10.1182/blood-2022-156631

Published: 2022

Journal Articles

Late Morbidity and Mortality after Autologous Blood or Marrow Transplantation (BMT) for Lymphoma in Children, Adolescents and Young Adults - a Report from the BMT Survivor Study (BMTSS)

Anna Sallfors Holmqvist, Qingrui Meng, Chen Dai, Lindsey Hageman, Wendy Landier, Jessica Wu, Liton F. Francisco, Elizabeth Schlichting, Nora Balas, Alysia Bosworth, Hok Sreng Te, Ravi Bhatia, Joseph Rosenthal, Lennie Wong, Daniel J. Weisdorf, Saro H. Armenian, Smita Bhatia

Blood (2022) 140 (Supplement 1): 1190–1192.

https://doi.org/10.1182/blood-2022-156349

Published: 2022

Journal Articles

Activating a Non-Genetic MYC-Regulating Pathway Sensitizes Acute Myeloid Leukemia to Bromodomain Inhibition

Xinyue Zhou, Steven Moreira, Hong Wang, Pengcheng Zhang, Yang Zhou, Ravi Bhatia, Chunliang Li, Kristin Hope, Rui Lu

Blood (2022) 140 (Supplement 1): 8735.

https://doi.org/10.1182/blood-2022-167049

Published: 2022

Journal Articles

Specific Clonal Mutations Are Predictive of Therapy-Related Myeloid Neoplasms (tMN) after Autologous Peripheral Blood Stem Cell Transplantation (aPBSCT) for Lymphoma

Smita Bhatia, Chengcheng Yan, Melissa A Richard, Jianbo He, Alysia Bosworth, David Crossman, Purnima Singh, Lindsey Hageman, Saro H. Armenian, Julie M. Vose, Daniel J. Weisdorf, Yutaka Yasui, Benjamin L. Ebert, Christopher J. Gibson, Stephen J Forman, Ravi Bhatia

Blood (2022) 140 (Supplement 1): 295–297.

https://doi.org/10.1182/blood-2022-165604

Published: 2022

Journal Articles

Individual Prediction of Cardiovascular Events in Blood or Marrow Transplant Survivors - a BMT Survivor Study Report

Radhika Gangaraju, Yanjun Chen, Lindsey Hageman, Wendy Landier, Nora Balas, Elizabeth Schlichting, Liton F. Francisco, Alysia Bosworth, Hok Sreng Te, Lennie Wong, Daniel J. Weisdorf, Ravi Bhatia, Stephen J Forman, Saro H. Armenian, Smita Bhatia

Blood (2022) 140 (Supplement 1): 5142–5143.

https://doi.org/10.1182/blood-2022-167073

Published: 2022

Journal Articles

Fattening up FLT3-ITD for the kill

Ravi Bhatia

Blood (2021) 138 (22): 2158–2159.

https://doi.org/10.1182/blood.2021013182

Published: 2021

Journal Articles

Trends in Late Mortality and Life Expectancy after Autologous Blood or Marrow Transplantation (BMT) Performed over Three Decades - a BMT Survivor Study (BMTSS) Report

Blood (2021) 138 (Supplement 1): 484.

https://doi.org/10.1182/blood-2021-149720

Published: 2021

Journal Articles

Hypomethylating Agent/Venetoclax Versus Intensive Chemotherapy in Relapsed or Refractory Acute Myeloid Leukemia

Omer Hassan Jamy, Sarah Worth, Sravanti Rangaraju, Kimo Bachiashvili, Pankit Vachhani, Ravi Bhatia

Blood (2021) 138 (Supplement 1): 2322.

https://doi.org/10.1182/blood-2021-149778

Published: 2021

Journal Articles

Essential Roles of Transcription Factor MEF2D in the Maintenance of MLL-Rearranged Acute Myeloid Leukemia

Pengcheng Zhang, Lianzhong Zhao, Shaowei Qiu, Ravi Bhatia, Rui Lu

Blood (2021) 138 (Supplement 1): 2218.

https://doi.org/10.1182/blood-2021-149232

Published: 2021

Journal Articles

Risk Factors and Outcomes of ICU Admission Following Allogeneic Hematopoietic Stem Cell Transplantation

Omer Hassan Jamy, John Dasher, Yanjun Chen, Kevin D. Battles, Donna Salzman, Antonio Di Stasi, Ravi Bhatia, Smita Bhatia

Blood (2021) 138 (Supplement 1): 1784.

https://doi.org/10.1182/blood-2021-145234

Published: 2021

NARROW

Epigenetic regulation of noncanonical menin targets modulates menin inhibitor response in acute myeloid leukemia

Low-Dose Decitabine Plus Venetoclax As Post-Transplant Maintenance for High-Risk Myeloid Malignancies

Leukaemia Exposure Alters the Transcriptional Profile and Function of Macrophages in the Bone Marrow Niche

Addition of Single Dose Gemtuzumab Ozogamicin to Intensive Induction Chemotherapy in Core-Binding Factor Acute Myeloid Leukemia

Real-World Evidence of Treatment-Free Remission in Chronic Myeloid Leukemia at an Academic Center in the Deep South

Idarubicin and Cytarabine with and without Midostaurin for FLT3-Mutated Acute Myeloid Leukemia

Metabolic adaptation to tyrosine kinase inhibition in leukemia stem cells

The Anti-Leprosy Agent Clofazimine Inhibits FLT3-ITD Mutant AML Stem Cells and Potently Enhances Effects of TKI

Optimal Induction and Consolidation Strategy for Patients with Complex Karyotype and TP53 -Mutated Acute Myeloid Leukemia

PRMT5 Inhibition Enhances Elimination of FLT3-ITD AML Stem Cells in Combination with TKI Treatment

Metabolic Adaptation to Tyrosine Kinase Inhibition in Chronic Myelogenous Leukemia Stem Cells

Late Morbidity and Mortality after Autologous Blood or Marrow Transplantation (BMT) for Lymphoma in Children, Adolescents and Young Adults - a Report from the BMT Survivor Study (BMTSS)

Activating a Non-Genetic MYC-Regulating Pathway Sensitizes Acute Myeloid Leukemia to Bromodomain Inhibition

Specific Clonal Mutations Are Predictive of Therapy-Related Myeloid Neoplasms (tMN) after Autologous Peripheral Blood Stem Cell Transplantation (aPBSCT) for Lymphoma

Individual Prediction of Cardiovascular Events in Blood or Marrow Transplant Survivors - a BMT Survivor Study Report

Fattening up FLT3-ITD for the kill

Trends in Late Mortality and Life Expectancy after Autologous Blood or Marrow Transplantation (BMT) Performed over Three Decades - a BMT Survivor Study (BMTSS) Report

Hypomethylating Agent/Venetoclax Versus Intensive Chemotherapy in Relapsed or Refractory Acute Myeloid Leukemia

Essential Roles of Transcription Factor MEF2D in the Maintenance of MLL-Rearranged Acute Myeloid Leukemia

Risk Factors and Outcomes of ICU Admission Following Allogeneic Hematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only